Paxalisib Plus Olaparib or Pembrolizumab/Chemotherapy in Advanced Breast Cancer
ACTRN 12624001340527 Brief Summary This study aims to learn about the safety…
Read more arrow_forwardACTRN 12624001340527 Brief Summary This study aims to learn about the safety…
Read more arrow_forwardACTRN 12623000959673 Brief Summary This study is evaluating the safety and properties…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forwardNCT 06249048 Brief Summary Phase 1/2, Open-label, Multi-center, First-in-human Study of the…
Read more arrow_forwardNCT 04106492 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05886868 Brief Summary This is the first in human study of…
Read more arrow_forward